Day: April 18, 2022

SAN FRANCISCO, April 18, 2022 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading destination for learning and teaching online, today announced it will release its financial results for its fiscal first quarter 2022 on Wednesday, May 4, 2022. After market close, Udemy will post a news release on the Udemy website. Udemy will then host a live audio webcast beginning at 5:00 p.m. EDT / 2:00 p.m. PDT on the same day to discuss the company’s financial results and business highlights. Interested parties may access the conference call by registering here. The conference call will also be webcast live on the Udemy Investor Relations website at https://investors.udemy.com/. Shortly after the conclusion of the live earnings call, an archived replay of the webcast will be available on the Udemy Investor Relations website at https://investors.udemy.com/. About...

YONKERS, N.Y., April 18, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections, announces today that the Company has been selected for an oral presentation and six poster presentations at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) Annual Meeting to be held from April 23-26, 2022 in Lisbon, Portugal. The data being presented will feature exebacase, the Company’s Breakthrough Therapy designated product candidate currently being studied in a pivotal Phase 3 superiority design study, CF-370, an engineered lysin product candidate demonstrating...

Transition to take effect June 1st, 2022 SAULT STE. MARIE, Ontario, April 18, 2022 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or the “Company”), a leading Canadian producer of hot and cold rolled steel sheet and plate products, today announced the appointment of Michael Garcia as Chief Executive Officer (“CEO”) effective June 1st, 2022 upon the retirement of current CEO Michael McQuade. Mr. McQuade will continue to serve on the Company’s board of directors (the “Board”) and Mr. Garcia will also join the Board concurrent with his appointment as CEO.   Andy Harshaw, Chairman of the Board, commented, “Mike McQuade has provided exemplary leadership through this transition period, taking Algoma from restructuring to a publicly listed company. He has set Algoma on secure footing as the company advances...

NFI – New Flyer Xcelsior® Hybrid-Electric NFI – New Flyer Xcelsior® Hybrid-Electric busWINNIPEG, Manitoba, April 18, 2022 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI”), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, today announced that its subsidiary New Flyer Industries Canada ULC (“New Flyer”) has received new firm orders from the Toronto Transit Commission (“TTC”) for 134 Xcelsior® forty-foot hybrid-electric heavy-duty transit buses, and 68 Xcelsior sixty-foot hybrid-electric buses (136 equivalent units or “EUs”) for a total of 270 EUs. The two four-year contracts include options for up to an additional 263 forty-foot hybrid-electric buses and 100 sixty-foot buses, respectively. In total, NFI will add 733 EUs to its backlog from...

•  Ocugen responsible for commercialization of COVAXIN™ in Mexico •  COVAXIN™, already authorized for emergency use in adults by health regulators in Mexico, has been submitted for Emergency Use Authorization for children aged 2-18 years MALVERN, Pa. and HYDERABAD, India, April 18, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals and vaccines, and Bharat Biotech (BBIL), a global leader in vaccine innovation, today announced that they have entered into an amendment to their Co-development, Supply and Commercialization Agreement to expand Ocugen’s exclusive territory to include commercialization of COVAXIN™ in Mexico. This gives Ocugen COVAXIN™ commercialization rights for all of North America. “We’re excited...

The Company is currently installing an additional automotive shredder and downstream system which is expected to double its processing capacity NORFOLK, Va., April 18, 2022 (GLOBE NEWSWIRE) — Greenwave Technology Solutions, Inc. (“Greenwave” or the “Company”) (OTCPink:GWAV) is pleased to report that it generated revenues of approximately $9.7 million during the first quarter of 2022, an increase of 63.5% from the $5.9 million in revenue Empire Services, Inc. (“Empire”) generated in the same period in 2021. Greenwave, through its subsidiary Empire, currently operates 11 metal recycling facilities in Virginia and North Carolina. Empire generated $27.75 million in revenue during the year ended December 31, 2021, up from $12.96 million during the year ended December 31, 2020, an increase of approximately 114%....

– Clinical update expected in second half of 2023 – CAMBRIDGE, Mass. and NEW YORK, April 18, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced the dosing of the first patient in the Phase 1 study evaluating BDTX-1535, a MasterKey inhibitor of epidermal growth factor receptor (EGFR) for the treatment of both non-small cell lung cancer (NSCLC) and glioblastoma (GBM)derived from Black Diamond’s MAP discovery engine. “The dosing of the first patient in our Phase 1 study of BDTX-1535, a next generation brain-penetrant inhibitor of oncogenic EGFR MasterKey mutations is an important step as we believe this program is uniquely positioned to address the existing unmet needs of EGFR mutant...